APGE - Company ID 0001974640
As of 2026-09-08, Apogee Therapeutics, Inc. (APGE) has a market capitalization of $10.11 B, making it the #952 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-08 | $10.11 B |
| 2026-09-07 | $10.11 B |
| 2026-09-06 | $10.11 B |
| 2026-09-05 | $10.11 B |
| 2026-09-04 | $10.11 B |
| 2026-09-03 | $10.11 B |
| 2026-09-02 | $10.11 B |
| 2026-09-01 | $10.12 B |
| 2026-08-31 | $10.11 B |
| 2026-08-30 | $10.11 B |
| 2026-08-29 | $10.11 B |
| 2026-08-28 | $10.11 B |
As of 2026-09-08, Apogee Therapeutics, Inc. (APGE) has a market capitalization of $10.11 B, making it the #952 most valuable US-listed company.
Apogee Therapeutics, Inc. is the #952 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-27 | $10.11 B |
| 2026-08-26 | $10.11 B |
| 2026-08-25 | $10.10 B |
| 2026-08-24 | $10.09 B |
| 2026-08-23 | $10.09 B |
| 2026-08-22 | $10.09 B |
| 2026-08-21 | $10.09 B |
| 2026-08-20 | $10.09 B |
| 2026-08-19 | $10.09 B |
| 2026-08-18 | $10.08 B |
| 2026-08-17 | $10.08 B |
| 2026-08-16 | $10.08 B |
| 2026-08-15 | $10.08 B |
| 2026-08-14 | $10.08 B |
| 2026-08-13 | $10.07 B |
| 2026-08-12 | $10.08 B |
| 2026-08-11 | $10.08 B |
| 2026-08-10 | $10.08 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.